Two Sigma Advisers LP Invests $402,000 in ASP Isotopes Inc. (NASDAQ:ASPI)

Two Sigma Advisers LP bought a new stake in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 88,700 shares of the company's stock, valued at approximately $402,000. Two Sigma Advisers LP owned about 0.12% of ASP Isotopes at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. CenterBook Partners LP acquired a new stake in ASP Isotopes during the fourth quarter worth about $6,800,000. Geode Capital Management LLC increased its stake in ASP Isotopes by 5.1% during the fourth quarter. Geode Capital Management LLC now owns 1,175,450 shares of the company's stock worth $5,326,000 after acquiring an additional 57,027 shares during the last quarter. Two Sigma Investments LP acquired a new stake in ASP Isotopes during the fourth quarter worth about $1,980,000. Northern Trust Corp grew its stake in shares of ASP Isotopes by 15.5% in the fourth quarter. Northern Trust Corp now owns 435,688 shares of the company's stock valued at $1,974,000 after buying an additional 58,525 shares in the last quarter. Finally, Nuveen Asset Management LLC lifted its holdings in ASP Isotopes by 672.1% during the 4th quarter. Nuveen Asset Management LLC now owns 413,346 shares of the company's stock worth $1,872,000 after buying an additional 359,811 shares during the last quarter. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Stock Performance

ASP Isotopes stock traded up $0.60 during mid-day trading on Friday, hitting $9.36. 4,159,360 shares of the company's stock traded hands, compared to its average volume of 2,687,612. The firm has a 50 day moving average price of $6.32 and a 200 day moving average price of $5.47. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The company has a market cap of $702.58 million, a PE ratio of -15.34 and a beta of 3.56. ASP Isotopes Inc. has a one year low of $1.86 and a one year high of $9.50.

Insider Transactions at ASP Isotopes

In other news, COO Robert Ainscow sold 66,668 shares of ASP Isotopes stock in a transaction on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total transaction of $374,674.16. Following the transaction, the chief operating officer now owns 1,419,992 shares in the company, valued at approximately $7,980,355.04. The trade was a 4.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Paul Elliot Mann sold 316,667 shares of the business's stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total value of $1,820,835.25. Following the completion of the transaction, the chief executive officer now owns 7,948,787 shares in the company, valued at $45,705,525.25. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 766,667 shares of company stock valued at $4,358,502. Corporate insiders own 21.40% of the company's stock.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group boosted their price objective on ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a research report on Wednesday, May 21st.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.